glp-1 boom drug set to disrupt food companies GLP-1 boom causing pharma FOMO
Description
The pharmacology of drugs such as Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual incretin receptor agonists is mainly characterized by two mechanisms of action
Recent research highlights common nutrient insufficiencies in the general population that may be amplified by reduced food consumption
For clinicians seeking quick updates on evidence, resources like PubMed can help locate peerreviewed studies, and databases such as ClinicalTrials.gov list active investigations
[Abstract] J Invest Dermatol
This allows the tech to work while your body is still in its most active change phase
